1. Home
  2. Category
  3. Treatment Types

Chemotherapy

Essentials

On-Body Injector: An Administration Device for Pegfilgrastim

Linda J. Mahler
Regina DiBlasi
Anielka Perez
Jeannie Gaspard
Dayna McCauley
CJON 2017, 21(1), 121-122 DOI: 10.1188/17.CJON.121-122
Many chemotherapy regimens used today require the support of a granulocyte–colony-stimulating factor for the prevention of life-threatening neutropenia. In March 2015, a delivery method was introduced for Neulasta® (pegfilgrastim) through an on-body injector (Onpro®), which may eliminate the need...
0
No votes yet
Read this Article
Article

Patient-Reported Self-Efficacy, Anxiety, and Health-Related Quality of Life During Chemotherapy: Results From a Longitudinal Study

Constantina Papadopoulou
Grigorios Kotronoulas
Annegret Schneider
Morven I. Miller
Jackie McBride
Zoe Polly
Simon Bettles
Alison Whitehouse
Lisa McCann
Nora Kearney
Roma Maguire
ONF 2017, 44(1), 127-136 DOI: 10.1188/17.ONF.127-136
Purpose/Objectives: To explore changes over time in self-efficacy and the predictive ability of changes in state anxiety and health-related quality of life during chemotherapy. Design: Secondary analysis of a longitudinal dataset derived from a larger, multicenter study. Setting: Outpatient...
0
No votes yet
Read this Article
Article

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Michael N. Neuss
Terry R. Gilmore
Kristin M. Belderson
Amy L. Billett
Tara Conti-Kalchik
Brittany E. Harvey
Carolyn Hendricks
Kristine B. LeFebvre
Pamela B. Mangu
Kristen McNiff
MiKaela Olsen
Lisa Schulmeister
Ann Von Gehr
Martha Polovich
ONF 2017, 44(1), DOI: 10.1188/17.ONF.31-43
Purpose: To update the American Society of Clinical Oncology (ASCO)/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards and to highlight standards for pediatric oncology. Methods: The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and...
0
No votes yet
Read this Article
Article

Personal Protective Equipment Use and Hazardous Drug Spills Among Ambulatory Oncology Nurses

Bei Y. He
Kari Mendelsohn-Victor
Marjorie C. McCullagh
Christopher R. Friese
ONF 2017, 44(1), 60-65 DOI: 10.1188/17.ONF.60-65
Purpose/Objectives: To examine patterns and organizational correlates of personal protective equipment (PPE) use and hazardous drug spills. Design: Cross-sectional mailed survey. Setting: Ambulatory practices in California, Georgia, and Michigan. Sample: 252 Oncology Nursing Society members who...
0
No votes yet
Read this Article
Online Exclusive Article

Testing an Intervention to Decrease Healthcare Workers’ Exposure to Antineoplastic Agents

Catherine Graeve
Patricia M. McGovern
Susan Arnold
Martha Polovich
ONF 2017, 44(1), E10-E19 DOI: 10.1188/17.ONF.E10-E19
Purpose/Objectives: To develop and test a worksite intervention that protects healthcare workers who handle antineoplastic drugs from work-related exposures. Design: Intervention study. Setting: A university hospital in a large midwestern metropolitan area and its outpatient chemotherapy infusion...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.